Drug Trial Radar · NCT04532047
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
Last checked: Nov 20, 2026Latest source record: Mar 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Jul 1, 2021
Primary completion
Jul 31, 2031
Study completion Jul 31, 2032
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Duke University
- First posted
- Aug 31, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
For detailed information, please view our study website: https://pearltrial.ucsf.edu/ The investigators aims to determine the the maternal and fetal safety and feasibility of in utero fetal enzyme replacement therapy in fetuses with Lysosomal Storage Diseases.
Conditions
- MPS I
- MPS II
- MPS IVA
- MPS VI
- Mps VII
- Gaucher Disease, Type 2
- Gaucher Disease, Type 3
- Pompe Disease Infantile-Onset
- Wolman Disease
Interventions
Aldurazyme (laronidase)Drug
Enzyme replacement therapy for lysosomal storage diseases
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment-related adverse events as assessed by CTCAE v5.0.Time frame: 6 years
- Number of participants to receive the full initial, weight-based dose of enzyme replacement therapy through the fetal umbilical vein, and subsequent doses throughout the pregnancy.Time frame: 6 years
- Number of participants with the presence and levels of glycosaminoglycans (GAGs) in urine.Time frame: 6 years
- The number of participants with improvement or resolution of hydrops (if present).Time frame: 6 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California
San Francisco, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.